Vera Therapeutics (VERA) Amortization of Deferred Charges (2022 - 2026)
Vera Therapeutics (VERA) posted Amortization of Deferred Charges of $116000.0 for Q1 2026, up 2.65% on a QoQ basis from $113000.0 in Q4 2025, and down 74.62% year-over-year from $457000.0 in Q1 2025.
Vera Therapeutics (VERA) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Vera Therapeutics' Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $116000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 74.62% year-over-year to $116000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 44.71% YoY) and the FY2025 annual result came in at $1.4 million, down 29.8% from the prior year.
- Amortization of Deferred Charges was $116000.0 for Q1 2026 at Vera Therapeutics, up from $113000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $595000.0 in Q4 2022 and bottomed at $113000.0 in Q4 2025.
- A 5-year average of $477882.4 and a median of $532000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2024 — Amortization of Deferred Charges gained 3.01% — and 2025, when it plunged 79.38%.
- Vera Therapeutics' Amortization of Deferred Charges stood at $595000.0 in 2022, then decreased by 10.59% to $532000.0 in 2023, then climbed by 3.01% to $548000.0 in 2024, then plunged by 79.38% to $113000.0 in 2025, then increased by 2.65% to $116000.0 in 2026.
- Business Quant data shows VERA's Amortization of Deferred Charges at $116000.0 in Q1 2026, $113000.0 in Q4 2025, and $435000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Vera Therapeutics | 2.53 Bn | 2.53 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Dec 31, 2025 | 113,000.00 |
| Dec 31, 2025 | 113,000.00 |
| Sep 30, 2025 | 435,000.00 |
| Sep 30, 2025 | 435,000.00 |
| Jun 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 444,000.00 |
| Mar 31, 2025 | 457,000.00 |
| Mar 31, 2025 | 457,000.00 |
| Dec 31, 2024 | 548,000.00 |
| Dec 31, 2024 | 548,000.00 |
| Sep 30, 2024 | 496,000.00 |
| Sep 30, 2024 | 496,000.00 |
| Jun 30, 2024 | 503,000.00 |
| Jun 30, 2024 | 503,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 532,000.00 |
| Dec 31, 2023 | 532,000.00 |